<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Unlocking the Potential of Autologous Cell &amp;amp; Gene Therapy Through Digital Transformation</title><link>/industries/lifesciences/b/life-sciences-blog/posts/unlocking-the-potential-of-autologous-cell-gene-therapy-through-digital-transformation-1227819419</link><description>Autologous and personalized cell and gene therapies (CGTs) are at the frontier of modern medicine, offering potential cures for previously untreatable conditions. However, scaling these therapies presents complex challenges distinct from traditional pharmaceuticals</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>